Skip to main content

MJFF Publications

1781 - 1790 of 7730 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • RESTRICTED
    Title: Improving functional disability in patients with tremor: A clinical perspective of the efficacies, considerations, and challenges of assistive technology
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2022.120197
    Citation Count: 13
  • RESTRICTED
    Title: Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson’s disease
    Journal Name: Stem Cell Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.scr.2022.102733
    Citation Count: 3
  • RESTRICTED
    Title: La thérapie comportementale et cognitive pour l’anxiété dans la maladie de Parkinson induit des modifications cérébrales fonctionnelles
    Journal Name: Revue Neurologique
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurol.2022.02.152
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Levodopa-induced dyskinesia: a brief review of the ongoing clinical trials
    Journal Name: Neurodegenerative Disease Management
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.2217/nmt-2021-0051
    Best OA location URL:
    Citation Count: 3
  • RESTRICTED
    Title: Mechanisms underlying ubiquitin-driven selective mitochondrial and bacterial autophagy
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.molcel.2022.03.012
    Citation Count: 52
  • RESTRICTED
    Title: Minimal clinically important change in Abnormal Involuntary Movement Scale score in tardive dyskinesia as assessed in pivotal trials of deutetrabenazine
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.02.017
    Citation Count: 4
  • RESTRICTED
    Title: Mitochondrial complex IV defects induce metabolic and signaling perturbations that expose potential vulnerabilities in HCT116 cells
    Journal Name: FEBS Open Bio
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/2211-5463.13398
    Citation Count: 2
  • RESTRICTED
    Title: Multi-modality machine learning predicting Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00288-w
    Citation Count: 53
  • RESTRICTED
    Title: New insights into the genetic etiology of Alzheimer’s disease and related dementias
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41588-022-01024-z
    Citation Count: 816
  • RESTRICTED
    Title: Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's disease
    Journal Name: Neurodegenerative Disease Management
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.2217/nmt-2021-0057
    Citation Count: 4
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.